⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1474 | 0.69 | — | — | |
| SCHEMBL14937506 | 0.59 | — | — | |
| SCHEMBL102953 | 0.49 | — | — | |
| SCHEMBL374036 | 0.46 | — | — | |
| SCHEMBL321677 | 0.46 | — | — | |
| SCHEMBL2718753 | 0.46 | — | — | |
| SCHEMBL1178 | 0.42 | — | — | |
| Hydrochloric Acid SCHEMBL4026914 | 0.39 | — | — | |
| Hydrochloric Acid SCHEMBL552 | 0.39 | — | — | |
| Hydrochloric Acid SCHEMBL21351719 | 0.39 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0894107-B1 | COMPOUNDS WITH SPIRO ATOMS AND THEIR USE AS ELECTROLUMINESCENT MATERIALS | AVENTIS RES & TECH GMBH & CO (DE) | 1999-12-22 | — | — | EP | claimed |
| EP-3853237-B1 | PHOSPHONATE-CONTAINING CROSSLINKERS | UNIV UTRECHT HOLDING BV (NL) | 2024-04-24 | — | — | EP | disclosed |
| EP-3853237-A1 | PHOSPHONATE-CONTAINING CROSSLINKERS | Universiteit Utrecht Holding B.V. (NL) | 2021-07-28 | — | — | EP | disclosed |
| WO-2020060412-A1 | PHOSPHONATE-CONTAINING CROSSLINKERS | UNIVERSITEIT UTRECHT HOLDING B.V. (NL) | 2020-03-26 | — | — | WO | disclosed |
| US-9040221-B2 | Radiation-sensitive resin composition, method for forming resist pattern, and polymer and compound | JSR CORPORATION (JP) | 2015-05-26 | — | — | US | disclosed |
| US-20130122426-A1 | RADIATION-SENSITIVE RESIN COMPOSITION, METHOD FOR FORMING RESIST PATTERN, AND POLYMER AND COMPOUND | JSR CORPORATION (JP) | 2013-05-16 | — | — | US | disclosed |
| US-20130012430-A1 | INHIBITORS OF SERINE PROTEASES, PARTICULARLY HEPATITIS C VIRUS NS3 PROTEASE | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2013-01-10 | — | — | US | disclosed |
| US-8314141-B2 | Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2012-11-20 | — | — | US | disclosed |
| EP-2409985-A2 | Inhibitors de serine proteases, especially of the NS3 protease of the hepatitis C virus | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2012-01-25 | — | — | EP | disclosed |
| US-20110112114-A1 | INHIBITORS OF SERINE PROTEASES, PARTICULARLY HEPATITIS C VIRUS NS3 PROTEASE | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2011-05-12 | — | — | US | disclosed |
| US-6608067-B1 | Treating hepatitis C viral infection | VERTEX PHARMACEUTICALS INCORPORATED | 2003-08-19 | — | — | US | disclosed |
| US-20020032175-A1 | Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease | VERTEX PHARMACEUTICALS INCORPORATED | 2002-03-14 | — | — | US | disclosed |
| EP-0932617-B1 | INHIBITORS OF SERINE PROTEASES, PARTICULARLY HEPATITIS C VIRUS NS3 PROTEASE | VERTEX PHARMA (US) | 2002-01-16 | — | — | EP | disclosed |
| EP-1136498-A1 | Inhibitors of serine proteases, particularly hepatitis c virus NS3 protease | Vertex Pharmaceuticals Incorporated (US) | 2001-09-26 | — | — | EP | disclosed |
| US-6265380-B1 | Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease | VERTEX PHARMACEUTICALS INCORPORATED | 2001-07-24 | — | — | US | disclosed |
| EP-1066247-A1 | INHIBITORS OF SERINE PROTEASES, PARTICULARLY HEPATITIS C VIRUS NS3 PROTEASE | Vertex Pharmaceuticals Incorporated (US) | 2001-01-10 | — | — | EP | disclosed |
| WO-1999050230-A1 | INHIBITORS OF SERINE PROTEASES, PARTICULARLY HEPATITIS C VIRUS NS3 PROTEASE | VERTEX PHARMACEUTICALS INCORPORATED (US) | 1999-10-07 | — | — | WO | disclosed |
| EP-0932617-A1 | INHIBITORS OF SERINE PROTEASES, PARTICULARLY HEPATITIS C VIRUS NS3 PROTEASE | Vertex Pharmaceuticals Incorporated (US) | 1999-08-04 | — | — | EP | disclosed |
| US-5763636-A | CONJUGATED POLYCYCLIC POLYMERS | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-06-09 | — | — | US | disclosed |
| WO-1998017679-A1 | INHIBITORS OF SERINE PROTEASES, PARTICULARLY HEPATITIS C VIRUS NS3 PROTEASE | VERTEX PHARMACEUTICALS INCORPORATED (US) | 1998-04-30 | — | — | WO | disclosed |